首页 | 本学科首页   官方微博 | 高级检索  
   检索      


Construction and expression of immunogenic hybrid enterotoxigenic Escherichia coli CFA/I and CS2 colonization fimbriae for use in vaccines
Authors:Joshua Tobias  Ann-Mari Svennerholm  Jan Holmgren  Michael Lebens
Institution:(1) University of Gothenburg Vaccine Research Institute (GUVAX), P.O. Box 435, 40530 Gothenburg, Sweden;(2) WHO Collaborating Center for Research on enterotoxigenic Escherichia coli (ETEC), P.O. Box 435, 40530 Gothenburg, Sweden;(3) Department of Microbiology and Immunology, The Sahlgrenska Academy of University of Gothenburg, P.O. Box 435, 40530 Gothenburg, Sweden;(4) Department of Microbiology and Immunology, University of Gothenburg, P.O. Box 435, 40530 Gothenburg, Sweden
Abstract:Enterotoxigenic Escherichia coli (ETEC) are an important cause of diarrheal morbidity in developing countries, especially in children and also of traveler's diarrhea. Colonization factors (CFs) of ETEC, like CFA/I and CS2 which are genetically and structurally related, play a substantial role in pathogenicity, and since intestinal–mucosal immune responses against CFs appear to be protective, much effort has focused on the development of a CF-based ETEC vaccine. We have constructed hybrid operons in which the major CS2 subunit-encoding cotA gene was inserted into the CFA/I operon, either replacing (hybrid I) or being added to the major CFA/I subunit-encoding cfaB gene (hybrid II). Using specific monoclonal antibodies against the major subunits of CFA/I and CS2, high levels of surface expression of both fimbrial subunits were shown in E. coli carrying the hybrid II operon. Oral immunization of mice with formalin-killed bacteria expressing hybrid II fimbriae induced strong CFA/I- and CS2-specific serum IgG + IgM and fecal IgA antibody responses, which were higher than those achieved by similar immunization with the reference strains. Bacteria expressing hybrid fimbriae are potential candidate strains in an oral-killed CF-ETEC vaccine, and the approach represents an attractive and novel means of producing a broad-spectrum ETEC vaccine.
Keywords:
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号